Skip to main content
SpringerLink
Log in

Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

Helicobacter pylori (H. pylori) was reported to be associated with gastric carcinogenesis. Resistin-like molecule beta (RELMβ), a recently described goblet cell-specific protein, was demonstrated to aberrantly express in gastric cancer and correlated with its clinicopathological features. This study aimed to examine the association between H. pylori and RELMβ expression in gastric carcinoma and precursor lesions. H. pylori infection and RELMβ expression were immunohistochemically evaluated in gastric biopsies from 230 patients. The biopsies consisted of normal gastric mucosa (n=20), mucosa with chronic gastritis (n=41), intestinal metaplasia (n=42), dysplasia (n=31), intestinal-type adenocarcinoma (n=56), and diffuse-type adenocarcinoma (n=40). RELMβ expression was measured in gastric biopsies after H. pylori eradication therapy in a subgroup of 32 patients. Cultured gastric cancer cell line SGC-7901 was infected with H. pylori strains, and RELMβ expression was detected by reverse transcription PCR, real-time PCR and Western blotting. Higher RELMβ immunoreactivity was observed in H. pylori-positive intestinal metaplasia (P=0.003), dysplasia (P=0.032), intestinal-type (P=0.037) and diffuse-type adenocarcinomas (P=0.001) than in H. pylori-negative specimens. Expression rates of RELMβ in dysplasia (P=0.005), intestinal-type adenocarcinoma (P<0.001), and diffuse-type adenocarcinoma (P=0.001) were significantly correlated with the grade of H. pylori density. In addition, H. pylori eradication reduced the RELMβ intensity in intestinal metaplasia (P=0.001). Infection of gastric cancer SGC-7901 cells with cag pathogenicity island (PAI)-positive H. pylori TN2, but not with its PAI totally deleted mutant (TN2-ΔPAI) for 4–8 h, resulted in enhanced protein and transcript levels of RELMβ (P<0.05). In summary, our study suggested that H. pylori infection facilitated the expression of RELMβ in gastric garcinoma and precursor lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shah MA, Kelsen DP. Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw, 2010,8(4):437–447

    Article  CAS  Google Scholar 

  2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res, 1992,52(24):6735–6740

    CAS  PubMed  Google Scholar 

  3. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology, 1996,110(4):1244–1252

    Article  CAS  Google Scholar 

  4. Lee YC, Chiang TH, Chou CK, et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology, 2016,150(5):1113–1124

    Article  Google Scholar 

  5. Fujioka T, Honda S, Tokieda M. Helicobacter pylori infection and gastric carcinoma in animal models. J Gastroenterol Hepatol, 2000,15(Suppl):55–59

    Article  Google Scholar 

  6. Lauren P. The Two Histological Main Types Of Gastric Carcinoma: Diffuse And So-Called Intestinal-Type Carcinoma. Acta Pathol Microbiol Scand, 1965,64(1):31–49

    Article  CAS  Google Scholar 

  7. Correa P, Shiao YH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res, 1994,54(7 Supplement):1941s–1943s

    CAS  PubMed  Google Scholar 

  8. Steppan CM, Brown EJ, Wright CM, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA, 2001,98(2):502–506

    Article  CAS  Google Scholar 

  9. He W, Wang ML, Jiang HQ, et al. Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology, 2003,125(5):1388–1397

    Article  CAS  Google Scholar 

  10. Shojima N, Ogihara T, Inukai K, et al. Serum concentrations of resistin-like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow. Diabetologia, 2005,48(5):984–992

    Article  CAS  Google Scholar 

  11. Artis D, Wang ML, Keilbaugh SA, et al. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci USA, 2004,101(37):13 596–13 600

    Article  CAS  Google Scholar 

  12. Propheter DC, Chara AL, Harris TA, et al. Resistin-like molecule β is a bactericidal protein that promotes spatial segregation of the microbiota and the colonic epithelium. Proc Natl Acad Sci USA, 2017,114(42):11 027–11 033

    Article  CAS  Google Scholar 

  13. Zheng LD, Tong QS, Weng MX, et al. Enhanced expression of resistin-like molecule beta in human colon cancer and its clinical significance. Dig Dis Sci, 2009,54(2):274–281

    Article  CAS  Google Scholar 

  14. Zheng L, Tong Q, Weng M, et al. Expression of resistin-like molecule beta in Barrett’s esophagus: a novel biomarker for metaplastic epithelium. Dig Dis Sci, 2010,55(1):32–39

    Article  CAS  Google Scholar 

  15. Zheng L, Weng M, He J, et al. Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis. Virchows Arch, 2010,456(1):53–63

    Article  CAS  Google Scholar 

  16. Li D, Bautista MC, Jiang SF, et al. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study. Am J Gastroenterol, 2016,111(8):1104–1113

    Article  Google Scholar 

  17. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol, 1996,20(10):1161–1181

    Article  CAS  Google Scholar 

  18. Isomoto H, Kawazoe K, Inoue K, et al. Usefulness of the immunological rapid urease test for detection of Helicobacter pylori in patients who are reluctant to undergo endoscopic biopsies. Dig Dis Sci, 2006,51(12):2302–2305

    Article  Google Scholar 

  19. Nair MG, Guild KJ, Du Y, et al. Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation. J Immunol, 2008,181(7):4709–4715

    Article  CAS  Google Scholar 

  20. Hogan SP, Seidu L, Blanchard C, et al. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol, 2006,118(1):257–268

    Article  CAS  Google Scholar 

  21. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1984,1(8390):1311–1315

    Article  CAS  Google Scholar 

  22. Kuipers EJ, Perez-Perez GI, Meuwissen SG, et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst, 1995,87(23):1777–1780

    Article  CAS  Google Scholar 

  23. Take S, Mizuno M, Ishiki K, et al. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol, 2005,100(5):1037–1042

    Article  Google Scholar 

  24. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med, 2001,345(11):784–789

    Article  CAS  Google Scholar 

  25. Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol, 1988,83(5):504–509

    CAS  PubMed  Google Scholar 

  26. Hazell SL, Lee A, Brady L, et al. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis, 1986,153(4):658–663

    Article  CAS  Google Scholar 

  27. Marshall BJ, Barrett LJ, Prakash C, et al. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology, 1990,99(3):697–702

    Article  CAS  Google Scholar 

  28. Hazell SL, Evans DJ, Graham DY Jr. Helicobacter pylori catalase. J Gen Microbiol, 1991,137(1):57–61

    Article  CAS  Google Scholar 

  29. Crabtree JE, Shallcross TM, Heatley RV, et al. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut, 1991,32(12):1473–1477

    Article  CAS  Google Scholar 

  30. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum, 1994,61:1–241

  31. Wang RQ, Fang DC. Effects of Helicobacter pylori infection on mucin expression in gastric carcinoma and pericancerous tissues. J Gastroenterol Hepatol, 2006,21(2):425–431

    Article  CAS  Google Scholar 

  32. Zheng LD, Yang CL, Qi T, et al. Effects of resistin-like molecule beta over-expression on gastric cancer cells in vitro. World J Gastroenterol, 2012,18(8):754–766

    Article  CAS  Google Scholar 

  33. Shabelnik MY, Kostyuk OV, Merentsev SV, et al. Helicobacter pylori infection of gastric cancer cells elevates the level of expression and activation of protein kinase D2. Exp Oncol, 2009,31(3):134–139

    CAS  PubMed  Google Scholar 

  34. Hatakeyama M. The role of Helicobacter pylori CagA in gastric carcinogenesis. Int J Hematol, 2006,84(4):301–308

    Article  CAS  Google Scholar 

  35. Hatakeyama M, Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe, 2014,15(3):306–316

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Hong-jun Li & Li-duan Zheng

  2. Department of Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Er-hu Fang, Jian-qun Wang & Qiang-song Tong

Authors
  1. Hong-jun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Er-hu Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jian-qun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Li-duan Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qiang-song Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiang-song Tong.

Additional information

Conflict of Interest Statement

The authors declare that they have no competing interests.

This work was supported by the National Natural Science Foundation of China (Nos. 81071997, 81072073).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Hj., Fang, Eh., Wang, Jq. et al. Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions. CURR MED SCI 40, 95–103 (2020). https://doi.org/10.1007/s11596-020-2151-y

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-020-2151-y

Key words

Search

Navigation